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Structure of eukaryotic purine/Hþ symporter
UapA suggests a role for homodimerization in
transport activity
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The uric acid/xanthine Hþ symporter, UapA, is a high-afﬁnity purine transporter from the
ﬁlamentous fungus Aspergillus nidulans. Here we present the crystal structure of a genetically
stabilized version of UapA (UapA-G411VD1–11) in complex with xanthine. UapA is formed
from two domains, a core domain and a gate domain, similar to the previously solved
uracil transporter UraA, which belongs to the same family. The structure shows UapA in an
inward-facing conformation with xanthine bound to residues in the core domain. Unlike UraA,
which was observed to be a monomer, UapA forms a dimer in the crystals with dimer
interactions formed exclusively through the gate domain. Analysis of dominant negative
mutants is consistent with dimerization playing a key role in transport. We postulate that
UapA uses an elevator transport mechanism likely to be shared with other structurally
homologous transporters including anion exchangers and prestin.
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T
ransporters have evolved to speciﬁcally carry selected
molecules across membranes. Nucleobase–ascorbate trans-
porters (NATs), found in almost all species from bacteria
and fungi to plants and mammals, are responsible for cellular
uptake of essential metabolites1,2. In bacteria, plants and fungi,
NATs are speciﬁc for nucleobases, while human members of this
family transport ascorbate (vitamin C)3. NAT transporters also
have the capacity to mediate the uptake of toxic purine
analogues4,5. UapA from Aspergillus nidulans is speciﬁc for the
purines xanthine and uric acid but does not transport
hypoxanthine or adenine6. UapA is an intensively studied
transporter due to the development of simple genetic,
biochemical and cellular assays, possible in a model microbial
eukaryote, such as A. nidulans2. Such experiments have allowed
us, not only to gain an insight into the residues critical for
xanthine binding and transport by UapA, but importantly to also
isolate randomly generated mutations that change the speciﬁcity
of the protein and enable non-native substrates to be
transported7–9. In general, these mutations do not occur in the
binding site but rather in positions that could not have been
predicted a priori. In one experiment, 20 out of the 28 unbiased
mutations that enabled the fungus to use hypoxanthine were
observed to involve mutations of Arg481 (ref. 8). The structure of
the Escherichia coli homologue, UraA10, however, failed to
provide an adequate explanation for this, or indeed for other
mutations that affect speciﬁcity.
UapA has previously been shown to exist as dimers in the
membrane and in detergent-based solution11. As with other
transporters12, there is evidence that UapA oligomerization is
important for trafﬁcking of UapA to the plasma membrane11.
Oligomerization is suggested to have a potential role in the
function of other transporters, however as yet these observations
lack a detailed structural context13–16. It is currently unclear
whether dimerization has a functional role in UapA.
Here we present the structure of UapA, which has allowed us
to put the large body of genetic studies in a structural context and
provide evidence for dimerization playing a key role in
transporter function.
Results
Overall structure of UapA reveals homodimer formation.
A thermostabilized construct of UapA with a single-residue
substitution, G411V, and lacking the N-terminal 11 residues
(UapA-G411VD1–11)17 was expressed in Saccharomyces cerevisiae
as a green ﬂuorescent protein (GFP) fusion protein18.
UapA-G411VD1–11 binds xanthine but is transport inactive17,19.
The structure in complex with xanthine was solved by single
isomorphous replacement with anomalous scattering and reﬁned
at a resolution of 3.7 Å to an R-factor of 29.6% and Rfree of 32.7%
(Supplementary Table 1).
The overall structure of UapA contains 14 transmembrane
domains (TMs) organized into a 7þ 7 TM fold divided into a
core (TMs 1–4 and 8–11) and a gate (TMs 5–7 and 12–14)
domain, similar to UraA10 (Fig. 1a,b and Supplementary Fig. 1).
A key feature is that TMs 3 and 10 only extend halfway through
the protein, being followed by short b-strands and random coils
that crossover in the centre of the protein (Fig. 1a,b). Compared
with the bacterial protein UraA, UapA contains substantially
longer loop regions (Supplementary Fig. 2). Interestingly, the
extracellular loop between TMs 3 and 4 contains a disulphide
bond between Cys174 and Cys185, residues highly conserved in
fungi (Fig. 1b and Supplementary Fig. 3). Mutating either residue
to serine results in both marked reduction in heterologous
expression and almost complete abolition of sorting to the
membrane (Supplementary Fig. 3) indicating that the formation
of this disulphide bond is important for correct intracellular
folding and localization of UapA. This is also the case for other
eukaryotic membrane transport proteins20,21. UapA forms a
dimer with an extensive interface and a buried surface area of
6,000Å2, involving TMs 12, 13 and 14 of the gate domain. TM 13
is particularly closely associated with dimer formation, ﬁtting into
a cleft formed by the opposite monomer (Fig. 1c,d).
The UapA substrate-binding site. Density consistent with
xanthine is visible in a clearly deﬁned binding site approximately
halfway across the membrane in a cleft formed by the half helices
of TMs 3 and 10 (Fig. 2a; and extended data, Fig. 4), similar to the
uracil-binding site in UraA. A number of residues were predicted
to be involved in xanthine binding by previous mutational
analysis7,8,19. The current structure conﬁrms many of these
earlier predictions, revealing xanthine is within hydrogen-
bonding distance of the side chains of Gln408 (TM 10) and
Glu356 (TM 8), the main chain nitrogen of Ala407 at the N
terminus of TM 10 and the carbonyl oxygen of Val153 preceding
TM 3, as well as the main chain nitrogen of Phe155 of TM 3. The
phenyl rings of both Phe155 and Phe406 pack onto the xanthine
(Fig. 2b). The orientation of the substrate (Fig. 2b) is corroborated
by the position of the electron density peak in an anomalous
difference map obtained for a complex of UapA crystallized with
8-bromoxanthine (Supplementary Fig. 4), and with structure
activity relationships of xanthine analogues indicating Q408
interacts with N1–H and C2¼O of xanthine while E356 interacts
with N7–H (ref. 9). With the current structure we cannot
completely rule out the substrate adopting the alternative
conformation with E356 interacting with N9–H, however in
light of all the current evidence the most likely orientation of
xanthine is the one presented in Fig. 2b. The residues directly
interacting with the xanthine are all from the core domain and in
the structure a detergent molecule packs over the xanthine
separating it from TM 12 of the gate domain (Supplementary
Fig. 5). The xanthine is fully accessible to the inward-facing side
of the protein through this detergent-ﬁlled cavity.
The neighbouring subunit modulates substrate speciﬁcity.
Wild-type (WT) UapA cannot bind hypoxanthine or adenine
(Supplementary Fig. 6). However, mutants allowing uptake of
these purines have been isolated through unbiased genetic
approaches22. Mutants selected from these screens are shown in
Supplementary Fig. 6. The residues affected primarily fall into one
of three different regions of the protein. Phe406 (ref. 8) is located
within the binding site. Val463, Ala469 (TM 12)8, Thr526 (ref. 7)
and Phe528 (TM 14)22 are clustered at the interface between the
gate and core domains near to the substrate-binding site (Fig. 3a).
Gln113 and Ala441 (refs 7,8) are located distant from the binding
site in putative hinge regions between the two domains (Fig. 3a).
In addition, speciﬁcity mutations of Arg481 arise often in the
genetic screens8. These mutations do not affect transport of
physiological substrates but rather modulate the speciﬁcity of
the protein allowing low-afﬁnity transport of hypoxanthine or
adenine. At ﬁrst glance and considering the monomer in
isolation, the role of Arg481 in substrate speciﬁcity is difﬁcult
to interpret. However, the UapA dimer structure reveals that this
residue lies in close proximity to the xanthine-binding site, but of
the opposite monomer (Fig. 3b). MD simulations, in fact, suggest
that the bound xanthine and Arg481 come in much closer
proximity (2Å) than observed in the crystal structure (12Å)
(Supplementary Figs 7 and 8).
The most efﬁcient transport of hypoxanthine and adenine is
observed by combining mutations from the different regions
described above (Supplementary Fig. 6). Mutations within the
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binding site, such as Q408E, which allows efﬁcient binding
(Ki¼ 71mM) but no transport of hypoxanthine, or F406Y,
which permits only very low transport activity (42mM) for
hypoxanthine, when combined with mutations outside the
binding site (Q113L, A469E, T526M or F528S) convert UapA
into a very efﬁcient hypoxanthine and adenine transporter
(Supplementary Fig. 6). Similarly, combinations of mutations
in distinct speciﬁcity regions (Q113L/F528S, A441V/F528S,
V463I/F528S, A469E/F528S, R481G/F528S, R481G/T526M,
Q408E/R481G/F528S and Q408E/R481G/T526M) also result in
an expanded substrate proﬁle of UapA (Supplementary Fig. 6).
From the structure, we predicted that Phe155 and Leu459, both
involved in substrate co-ordination, might also have roles in
substrate speciﬁcity and indeed mutations of these residues
confer low-afﬁnity binding of hypoxanthine and adenine
(Supplementary Fig. 6).
Evidence that dimerization is required for function. Recent
genetic, cellular and biochemical studies demonstrated that
dimerization is critical for UapA trafﬁcking and turnover11.
However, the observed UapA dimer and the effect of Arg481 on
speciﬁcity prompted us to explore whether dimerization also has
a role in substrate transport. A second copy of UapA can be
co-expressed, through plasmid integration, together with the
endogenous copy, so that the overall UapA activity is roughly
doubled (Fig. 4c). We carried out co-expression experiments of
the endogenous WT UapA with each one of four kinetically
distinct UapA mutants exhibiting undetectable (G411V, Q408P
and N409D) or signiﬁcantly reduced (Q408E) transport activities,
when expressed in a purine uptake-deﬁcient strain. All mutants
showed similar protein expression levels to the WT7 and normal
localization into the plasma membrane (Fig. 4a). G411V and
N409D are capable of substrate binding, similar to the WT, but
lack detectable transport activity. Q408P has 4100-fold reduced
xanthine-binding afﬁnity (Km41mM) and consequently also
lacks detectable transport activity at low substrate concentrations.
Q408E has reduced transport activity (5–10% of the WT), a
nearly normal Km of xanthine or uric acid, but relatively high-
afﬁnity binding (71 mM) for hypoxanthine, which however cannot
be transported (Fig. 4a). WT UapA has a Km of 7.0±2.0 mM
(±indicates s.d., n¼ 9) for xanthine7,19. All mutants when
co-expressed with WT had a dominant negative effect for growth
on xanthine (Fig. 4b) and reduced [3H] xanthine uptake (28–41%
of WT), but had little effect on the Km value for xanthine
(4.3–5.2±1.4 mM, ±indicates s.d., n¼ 9; Fig. 4c). This strongly
suggests that in all cases the ‘heterodimeric’ complexes exhibited
low levels of transporter function, so that the transport rates
measured reﬂect mostly, if not entirely, the WT/WT UapA
dimers. As the G411V construct, for which the structure was
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Figure 1 | Structure of UapA. (a) Topology diagram of UapA. a-helices are represented by cylinders and b-strands by arrows. The substrate-binding site
between the amino termini of TMs 3 and 10 is indicated by the schematic of xanthine (cyan). The protein is arranged into two domains, a gate domain
consisting of TMs 5, 6, 7, 12, 13 and 14 (blue), and a core domain consisting of TMs 1, 2, 3, 4, 8, 9, 10 and 11 (red). The half helices and short b-strand
regions of TMs 3 and 10 (both part of the core domain) are coloured yellow and green, respectively. (b) Ribbon representation of the UapA monomer.
The gate domain is shown in blue while most of the core domain is shown in red. The amphipathic helices that link the core and gate domains are shown
in grey. Xanthine is shown in cyan as a space-ﬁlling model and the disulphide bond is shown in orange sticks. Only the N-terminal (residues 12–65)
and C-terminal (residues 546–574) ends are missing from the structure. (c) UapA dimer from the cytoplasmic side. One monomer is shown as in b, with
the helices numbered, and the other is shown in surface representation with the same colouring as in a. The xanthine in the surface representation is
labelled. (d) Surface representation of the dimer looking through the membrane. The pale blue lines indicate the likely location of the membrane.
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solved, was included in these experiments it seems unlikely
that this dominant negative effect could be due to effects of
the mutations on protein folding. Most importantly in the
Q408E/WT strain, UapA-mediated xanthine transport could be
signiﬁcantly inhibited by hypoxanthine, in contrast to the WT
control. This is clearest at 0.5mM hypoxanthine, where inhibition
in Q408E/WT is 48% but only 21% for WT (Fig. 4d).
Molecular dynamics support a role for Arg481 in the dimer.
Molecular dynamics simulations suggest a translocation pathway
from the binding site to the inside of the cell (Fig. 5a and
Supplementary Figs 7 and 8). Given the resolution of the crystal
structure, these data should be treated with caution; however,
the results are consistent with the biochemical data. Initially,
xanthine remains strongly ligated to Gln408 whilst tumbling
within the binding cavity. It interacts with Leu459, Val463 and
Ser466 close to the binding site while Arg481 of the opposite
monomer approaches the central binding cavity. This effectively
creates a speciﬁcity barrier on the pathway to the cytoplasm
with the xanthine forming transient H-bond and p–p stacking
interactions with Arg481 before ﬁnally moving to the cytosol with
characteristic conformational changes of the Arg481 side chain
and the Arg481–Gln408 interaction (Fig. 5a and Supplementary
Fig. 8). During this procedure there is a gradual displacement of
TM 10, which may be required for ligand exit.
UapA is likely to function by an elevator mechanism.
Comparison of the UapA structure with other transporters
provides additional insight into the translocation pathway and
transport cycle. Recently, structures have been determined of
members of the SLC26 (ref. 23) and SLC4 (ref. 24) transporter
families (Supplementary Fig. 9), showing them to be structurally
homologous to the NAT family. Taken individually, the core and
gate domains of UapA, UraA, anion exchanger 1 (AE1) and
SLC26Dg superimpose remarkably well, given their low sequence
homology. The largest outlier is the gate domain of UraA where
TMs 6 and 7 adopt a different position with respect to the two
central TMs of the domain (TMs 5 and 12). Overall, the major
differences between the proteins are the positions of the core
relative to the gate domain and, as has been reported previously,
transport is likely to be effected by the movement of one domain
against the other. Whereas UapA, UraA and SLC26Dg are all
inward facing, AE1 is outward facing. Arakawa et al.24 proposed a
mechanism based on the inward-facing UraA structure and the
outward-facing AE1 structure, although this was limited by
the substantially different gate domains in the two proteins. The
structure of UapA allows us to reﬁne the model. For UapA the
tight interaction between the gate domains at the dimer interface
suggests that this would remain relatively static and this is
reﬂected in the distribution of the temperature factors
(Supplementary Fig. 10). If we superpose all the structures by
their respective gate domains we see that the core domain of AE1
is displaced along the trajectory of TMs 1, 3, 8 and 10 by 10Å
Gate Core
Cytoplasm
1 83
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Q408 A407
T405
T404
10
G93 E356
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S154
a b
Figure 2 | Substrate-binding site and speciﬁcity regions of UapA.
(a) A monomer of UapA shown in grey with the key substrate-binding
regions of the protein coloured as in Fig. 1. The blue triangle indicates the
solvent-ﬁlled translocation channel from the substrate-binding site to the
cytoplasm. Xanthine is shown in cyan space-ﬁlling model. (b) Zoomed-in
version of the xanthine-binding site coloured as in Fig. 1 and with xanthine
shown in stick model. Residues involved in substrate binding are shown in
stick representation and labelled. Side chain and main chain groups of
Glu356, Gln408 and Ala407 and main chain groups of Phe155, Val153 are
all within H-bonding distance of the xanthine. Essentially the main contacts
are between the amide N of Phe155 and N9 of xanthine, Glu356 and N7–H,
Gln408 and N1–H and C2¼O, and the amide N of Ala407 and C6¼O. The
side chain groups of Phe155 and Phe406 also pack around the xanthine.
Other residues from TMs 1, 3 and 8 contribute to the architecture of the
binding site as indicated.
1
11
10
7 6
2
9
4
8
14
13
12
13′
5
3
Q113 A441
F406
L459
R481′
A469
V463
F155
F5
28
T526
R481
R481
a
b
Figure 3 | UapA substrate speciﬁcity. (a) Location of the different
residues involved in substrate speciﬁcity. The helical regions of the protein
are shown as cylinders coloured as in Fig. 1. TM 13 from the opposite
monomer is shown in light blue and indicated by the black dotted line,
which traces around the surface of the TM. For clarity the majority of the
loop regions of UapA have been removed. The individual residues involved
in substrate speciﬁcity are shown in magenta stick model and labelled.
Xanthine is shown in cyan stick model. (b) Structure of the UapA dimer as a
surface representation showing the close proximity of R481 from the
opposing monomer, to the substrate-binding site. TM 13 in both monomers
is shown in ribbon representation, with R481 indicated in stick
representation. Xanthine is shown with cyan carbon atoms.
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compared with the equivalent domain in the inward-facing
structures. Since the ligand in UapA is entirely located within
the core domain such a movement would effectively carry
the substrate across the membrane (Fig. 5b–d). Such an elevator
mechanism, ﬁrst described for Gltph25, has now been reported for
a number of different proteins26,27 including the sodium-proton
antiporters, which also contain two domains with the putative
substrate-binding site at the interface of two unwound helices in
the core domain28,29. This mechanism would be consistent with
the reported loss of activity when Gly411 is replaced with the
bulkier valine as in the crystallized G411VD1–11 construct.
The mutation clearly does not prevent xanthine binding, and
comparing TM 10 with the equivalent helix in UraA does not
indicate that it has a major effect on the local conformation of the
protein. It could instead sterically hinder the core domain from
gliding over the residues of the gate domain. A replacement of
Gly411 with Leu is also inactive, whereas the less bulky Pro or Ala
substitutions at this site retain activity19.
Discussion
UapA, like many other membrane transport proteins, is dimeric.
This was previously shown to be important for correct trafﬁcking
of the protein to the plasma membrane11. Our results suggest,
however, that dimer formation is also important for both
speciﬁcity and transport. First, the crystal structure shows that
the N terminus of TM 13 of one subunit, including the side chain
of Arg481, contributes to the inward-facing translocation channel
of the opposing subunit. It is interesting to note that Arg481 is the
most commonly mutated residue in genetic selection experiments
designed to alter the speciﬁcity of the protein to allow transport of
the non-native substrate, hypoxanthine8. Indeed, it is possible
that Arg481 from the opposite monomer acts as one of a number
of checkpoints ensuring transport of the correct substrate.
Second, dominant negative mutations indicate that one subunit
inﬂuences the transport function of the other. The exact
structural mechanism for this dominant negative effect is more
difﬁcult to pin down. There are a number of pointers towards an
elevator-type mechanism for this protein including the fact that
the xanthine in the structure exclusively interacts with residues of
the core domain. In addition, comparison of the inward-facing
UapA and the structurally homologous outward-facing AE1
(ref. 24) reveals a marked shift in the position of the core domain
relative to the gate domain. As an extension of this reasoning, the
structurally related human anion exchangers and prestin23,24 may
also use the elevator mechanism. Further work will be required to
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Figure 4 | Importance of dimer formation for UapA transport function. (a), In vivo inverted ﬂuorescence microscopy of growing hyphal cells of isogenic
strains expressing GFP-tagged WT UapA or mutant versions Q408P, Q408E, N409D or G411V, or co-expressing two copies of UapA (UapA/UapA) or a
copy of UapA with each one of the four mutants (Q408P/UapA, Q408E/UapA, N409D/UapA or G411V/UapA). In all cases UapA-GFP ﬂuorescence is
associated with the plasma membrane and the septa of growing hyphal cells, a picture typical of properly folded and correctly localized UapA7,8. Minor
cytoplasmic GFP labelling reﬂects the normal vacuolar turnover of UapA56. Scale bar shown in the UapA-GFP panel, 5 mm. (b) Relevant growth tests of
the same strains on either ammonium (NH4
þ ) or xanthine (Xa) as sole nitrogen sources. Notice that full growth on Xa occurs in UapA or UapA/UapA
strains, whereas co-expression of the selected loss-of-function mutants with WT UapA (last four subpanels) reduces growth. (c) Initial uptake rates of
[3H]-xanthine in strains expressing WT or mutant versions of UapA. Rates of WT UapA are taken as 100%. Measurable Km values for xanthine are also
indicated. Error bars represent s.d., n¼ 9. (d) The effect of hypoxanthine on [3H]-xanthine uptake on strains expressing WT UapA (blue line) or
co-expressing Q408E/UapA (red line) was assessed. Rates of xanthine uptake in the absence of hypoxanthine for both strains are taken as 100%. Ki values
are also indicated. Error bars represent s.d., n¼9. Note that solubility issues mean it is not possible to use higher concentrations of hypoxanthine.
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provide conclusive evidence. The question remains, however, how
a simple elevator mechanism would be consistent with the
dominant negative effect we observe for UapA. For the SWEET
transporters, which form trimers and most likely use a rocker
switch mechanism, dominant negative effects between subunits
were observed via changes in the cytoplasmic gate16,30. Almost all
the UapA mutations identiﬁed in the unbiased genetic screen that
allow the protein to transport the non-native substrates,
hypoxanthine and adenine (Supplementary Fig. 6), are seen
either at the interface between the core and gate domains or in the
linker between the two domains. These may have subtle effects on
transport by changing the relative positions of the gate and core
domains. Other conformational changes in addition to the
elevator movement are likely to be required during transport,
as seen for other proteins31. These may involve coupling
between the subunits of UapA, accounting for the dominant
negative effect. Our results however provide evidence for UapA
dimerization playing a role in ﬁne-tuning the substrate selectivity
process.
Methods
Expression and isolation of UapAG411VD1–11. The UapAG411VD1–11 construct
was generated using the QuikChange mutagenesis kit (Stratagene), and PCR
followed by cloning by homologous recombination into pDDGFP17. The sequences
of the oligonucleotide primers used for both mutagenesis and cloning are provided
in Supplementary Table 2. The expressed protein construct incorporates a
C-terminal tobacco etch virus cleavage site followed by a GFP-His8 tag32. The
UapAG411VD1–11 was transformed into the S. cerevisiae FGY217 strain33 and
positive transformants selected using -URA plates. Selected transformants were
grown in -URA medium with 0.1% glucose at 30 C, with shaking. Protein
expression was induced with a ﬁnal concentration of 2% galactose. After 22 h of
induction, the cells were collected by centrifugation before resuspension in cold cell
resuspension buffer (50mM Tris-HCl (pH 7.6), 1mM EDTA and 0.6M sorbitol)
supplemented with protease inhibitors (Roche). Cells were lysed using a cell
disruptor (Constant Systems) at 4–10 C. Unbroken cells and debris were removed
by centrifugation at 15,000g and 4 C for 10min and the membranes isolated by
further centrifugation at 150,000g at 4 C for 60min to isolate the membranes. The
supernatant was discarded and the membrane pellet resuspended in membrane
resuspension buffer (20mM Tris-HCl (pH 7.5) and 0.3M sucrose) to a ﬁnal
volume of 6ml l 1 starting cell culture using a handheld glass homogenizer (Kimble
Chase). The membranes were solubilized in membrane solubilization buffer (1
PBS, 150mM NaCl, 10% (v/v) glycerol, 1% (w/v) DDMLA (Generon) and protease
inhibitors) supplemented with 1mM xanthine (Sigma) or 8-bromoxanthine (see
below for details of the preparation) with constant stirring at 4 C for 1 h. The
sample was centrifuged (100,000g for 45min at 4 C) to remove insoluble material,
and imidazole at a ﬁnal concentration of 10mM was added to the detergent-
solublized material. The soluble protein was mixed with 20ml of Ni2þ -NTA
superﬂow resin (Qiagen) pre-equilibrated with buffer A (1 PBS, 150mM NaCl,
10mM imidazole (pH 7.5), 1mM xanthine or 8-bromoxanthine, and 0.03% (w/v)
DDMLA) at 4 C for 2 h. The resin was then packed into a glass econo-column (Bio-
Rad). Following extensive washing with buffer A supplemented with 10 and then
30mM imidazole, bound protein was eluted with ﬁve column volumes of buffer B
(20mM Tris-HCl (pH 7.5), 150mM NaCl, 1mM xanthine or 8-bromoxanthine, and
0.03% (w/v) DDMLA) supplemented with 250mM imidazole. The GFP tag was
removed from the fusion protein by treatment with an equimolar concentration of
His-tagged tobacco etch virus (TEV) protease. The protein sample was then dialysed
overnight in buffer B supplemented with 10% glycerol using 12-kDa molecular
weight cutoff dialysis tubing (Spectrum Labs). The remaining protein sample was
passed through a 0.22-mm ﬁlter (Millex) to remove any precipitation before loading
onto a 5-ml His-trap column (GE Biosciences). The His-tagged GFP and TEV
protease bind to the column, while the UapAG411VD1–11 is found in the ﬂow-
through. The UapAG411VD1–11 was concentrated to 0.5ml in 100-kDa molecular
weight cutoff ﬁlters (Millipore). Aggregates were removed from the sample by
centrifugation at 18,000g and 4 C for 10min. The sample was then loaded onto a
Superdex 200 10/300 gel ﬁltration column equilibrated with 20mM Tris (pH 7.5),
150mM NaCl, 0.6mM xanthine or 8-bromoxanthine, and 0.03% DDMLA (ref. 17).
The peak fractions were concentrated to 12mgml 1 using a 100-kDa molecular
weight cutoff ﬁlter (Millipore) and either used immediately for crystallization trials
or stored at  80 C.
Localization analysis of the C174S and C185S mutants. The C174S and C185S
mutants were generated (for mutagenic primer sequences see Supplementary
Table 2) in the UapAG411VD1–11 background and expressed as described above.
FGY217 cells expressing either the UapAG411VD1–11 or the C174S or C185S
mutants (in the UapAG411VD1–11 background) as C-terminal GFP fusion proteins
were collected by centrifugation and the expression level (mg l 1) of the different
constructs assessed using GFP ﬂuorescence based on a standard curve of known
GFP concentrations and taking into account the intrinsic ﬂuorescence (3,000
relative ﬂuorescence units) of uninduced FGY217 cells32. Two hundred-microlitre
aliquots of cells were ﬁxed in paraformaldehyde and then washed and resuspended
in KPO4/sorbitol before visualization using a Zeiss LSM-510 inverted confocal
microscope ﬁtted with a Plan-Apochromat  63 objective.
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Figure 5 | Substrate translocation pathway and transport mechanism in UapA. (a) Surface model of the UapA dimer showing the xanthine trajectory
during MD. The image is zoomed into the substrate translocation channel. The regions of the protein dimer are coloured as in Fig. 1, and R481 from the
opposite monomer is labelled. The positions adopted by the xanthine during translocation (Supplementary Figs 7 and 8) are coloured from the xanthine-
binding site (blue) to the intracellular side of the protein (red). (b–d) UapA is postulated to function using an elevator mechanism, involving displacement
of TMs 1, 3, 8 and 10 of the core domain, which effectively carries the substrate from one side of the membrane to the other. (b) Postulated outward-facing
structure of key regions of UapA, with the helices shown as cylinders. The positions of grey-coloured helices (TMs 1, 3, 8 and 10 from the core domain) are
modelled based on the outward-facing structure of AE1 (PDB 4YZF). The positions of helices 5 and 12 (blue) are as in the crystal structure. The arrow
indicates access to the postulated substrate-binding site shown by the grey space-ﬁlling model of xanthine. (c) Overlay of the helices 1, 3, 8 and 10 in the
postulated outward-facing conformation (grey) and the inward-facing conformation from the crystal structure (red). The position of xanthine in both
conformations is shown in grey (outward facing) and cyan (inward facing). The large grey–red-coloured arrow indicates the direction of movement of the
core domain helices during change from the outward- to inward-facing conformations. (d) Inward-facing conformation of the helices in blue and red as seen
in the crystal structure. Xanthine is shown in cyan. The large arrow indicates the substrate translocation trajectory from the binding site to the intracellular
side of the membrane (as seen in a). Although this seems to be the key conformational change it is possible that other domain movements are involved, for
example, TM 14 is kinked and this may need to ﬂex for the core to move. Interestingly Thr526 and Phe528, key for speciﬁcity, are located at this kink.
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Crystallization and structure determination. UapAG411VD1–11 crystals were
initially obtained using the MemSys/MemStart screen (Molecular Dimensions) in
vapour diffusion sitting drop plates. Optimized crystals were obtained in 0.1% MES
(pH 6.5), 30% PEG300, 0.03% DDMLA, 1% n-hexyl-b-D-glucopyranoside vapour
diffusion sitting drops at 20 C. Crystals appeared overnight and were frozen
immediately in liquid nitrogen for storage and transport to the synchrotron.
Data were collected at Diamond Light Source, UK. The crystals always showed
anisotropic diffraction, with the best crystals diffracting X-rays to Bragg spacings
of 3.5 Å in the strongest direction. Initial phases were calculated by single
isomorphous replacement with anomalous scattering using a crystal soaked
overnight with saturating concentrations of TaBr and an isomorphous crystal
that was treated with 10mM TaBr but showed no TaBr occupancy.
Diffraction images were processed using XDS34 through the Xia2 pipeline35 and
the CCP36 suite of programmes. The space group was determined to be P21 with
two molecules in the asymmetric unit. The heavy atom coordinates were
determined using SHELX37. Their positions were reﬁned and phases calculated
with SHARP38. The maps were improved by averaging over the two protomers of
the asymmetric unit, including the high-resolution data set as a second crystal in
dmmulti39. Initial maps showed clearly the positions of the transmembrane helices
and many of the linking loops. After building into these maps using Coot40 and
O (ref. 41) a model was obtained. Structural reﬁnement was performed using
PHENIX42 initially against data that had been anisotropy-corrected using the
diffraction anisotropy server. In the ﬁrst cycle DEN43 reﬁnement as implemented
in Phenix was carried out. Though this distorted the model it also resulted in
improved maps, which after averaging using RAVE44 enabled a better model to be
built, as judged by the behaviour in subsequent reﬁnement cycles. Reﬁnement was
carried out with the application of non-crystallographic symmetry and secondary
structure restraints with grouped B-factors and each of the two molecules of the
asymmetric unit assigned to a separate TLS group45. The model was improved by
interactive model building and reﬁnement with maps improved by NCS averaging
and B-factor sharpening46. Regular reﬁnement in Phenix was interspersed with
Rosetta reﬁnement47 again as implemented in Phenix. This gave signiﬁcantly
improved geometry and lower R-factors in subsequent cycles. In general the density
was better for molecule A where continuous density was obvious for all of the loop
regions enabling residues to be tentatively, given the low resolution, placed
(Supplementary Fig. 11). The residues that are outliers in the Ramachandran plot48
are all in these loop regions. In the ﬁnal structure monomer A contains all residues
from 66 to 545 while residues 133–144 are missing for monomer B. Xanthine was
placed in clear density between TMs 3 and 10. Density consistent with detergent
was also observed near to the substrate-binding site. This has been modelled as
dodecyl-b-D-maltoside, though the tails have been truncated, as we cannot
distinguish the two detergents in the crystallization screen. In the ﬁnal cycles of
reﬁnement all data to 3.7 Å were used rather than the anisotropy-corrected data.
Superimpositions were carried out with LSQMAN49 such that all matching Ca
pairs wereo3.8 Å apart after superposition. The solvent accessible areas as well as
the dimer interface area were calculated using AREAIMOL in the CCP4 suite36. A
summary of the crystallographic data collection and phasing statistics is given in
Supplementary Table 1. All crystallographic structure images were prepared using
PyMOL50.
Generation of an outward-facing UapA model. The human AE1 comprises 14
transmembrane helices classiﬁed into gate and core domains. The structure of AE1
was obtained in the outward-facing conformation and revealed that the two gate
domains form a dimer interface. TMs 5 and 12 both cover the substrate-binding
site in AE1 and are part of the dimerization domain. UapA was crystallized in the
inward open state. By superimposing the core domains of UapA and AE1, a rigid
movement of the core domains from the inward open to the outward open
states can be inferred. Superimposing both the gate domains of the UapA
dimer onto the gate domain of AE1 allowed us to postulate an outward open
conformation of UapA.
A. nidulans strains and growth conditions. Standard complete and minimal
media for A. nidulans were used. Media and supplemented auxotrophies were
at the concentrations given in the Fungal Genetics Stock Center database
(http://www.fgsc.net). Nitrogen sources were used at ﬁnal concentrations of 10mM
ammonium tartrate or 0.5mM uric acid or other purines. The recipient for
transformations was the uapAD uapCD azgAD pabaA1 argB2 mutant strain
lacking the endogenous uapA gene, as well as the genes encoding a secondary
xanthine/uric acid transporter (UapC) and the major purine transporter AzgA.
Plasmids carrying gfp-tagged WT or mutant versions of uapA were transformed
and strains selected on the basis of the argB (argB2) arginine auxotrophy
complementation51.
Construction of UapA mutants. Plasmids expressing mutant UapA-GFP versions
(Q408E, Q408P, N409D and G411V) used for the dominant negative analysis
(Fig. 4) were constructed previously19. For the present work, the following UapA
mutations were also made and functionally analysed: F155G, T404A, G411L,
L459A, Q408E/A469E, Q408E/R481G/T526M and Q408E/R481G/F528S. All uapA
mutations appearing in this work were generated using speciﬁc oligonucleotides
(details provided in Supplementary Table 2), the QuikChange Mutagenesis Kit and
plasmid pAN510exp-GFP carrying a gfp-tagged uapA gene, as a template7,51. For
construction of the double and triple mutants the Q408E mutation was introduced
by site-directed mutagenesis into existing vectors carrying the Q113L, A469E,
T526M, R481G/T526M and R481G/F528S mutations7,8. Mutations F406Y, A441V,
V463I, A469E and R481G were obtained previously as suppressors of mutation
F528S. The single mutations were separated from F528S by replacing the SacI/SacI
fragment from each double mutant with the corresponding fragment of
pAN510exp-GFP8. Q113L/F528S and R481G/T526M were constructed previously
by replacing the ClaI/XbaI fragment of pAN510exp-UapA-Q113L or the
SacI/SacI fragment of pAN510exp-UapA-T526M with the corresponding
fragments from pAN510exp-UapA-F528S or pAN510exp-UapA-R481G,
respectively8. GFP C-terminal tagging has previously shown to have absolutely
no effect on UapA transporter kinetics51. Mutant alleles of uapA were introduced
by genetic transformation52. Transformants selected on arginine auxotrophy
complementation were puriﬁed and those arising from single-copy plasmid
integration, as evidenced by PCR and Southern blot analysis, identiﬁed. Selected
transformants were tested for their ability to grow on uric acid or xanthine (major
UapA substrates) or other purines at 25 or 37 C, at pH 6.8, and for their
subcellular localization, using epiﬂuorescence inverted microscopy (Zeiss Observer
Z1/AxioCam HR R3 camera/Zen lite 2012 software). Samples for standard
ﬂuorescence microscopy were prepared as previously described53. Strains
co-expressing from the native uapA promoter WT UapA (that is, from the
endogenous genetic locus53) and UapA-Q408P, UapA-Q408E, UapA-G411V or
UapA-N409D (from single-copy plasmid integrations in the argB locus19), were
constructed by standard genetic crossing of two parental strains, one expressing the
WT gene and the other expressing the mutant allele. Previous experiments have
shown that UapA steady-state levels arising from expression from its endogenous
genetic locus, or from single-copy plasmid integration in the argB locus, are very
similar. Consequently, the transport rate in the strain expressing two copies of WT
UapA is nearly double (B185%). In a negative control strain carrying a deletion of
the uapA gene (uapAD), xanthine uptake is insigniﬁcant (o10%), because the
genetic background used, in all cases, also lacks all other transporters speciﬁc for
purines. Mutations Q408P, Q408E, G411V and N409D lead to UapA versions that
are normally localized in the plasma membrane, but show no or very low (5–10%)
transport activity, under standard uptake conditions.
Transport assays. UapA mutants were functionally characterized by uptake assays
performed in living cells. Radiolabelled [3H]-xanthine (22.8 Cimmol 1, Moravek
Biochemicals, CA, USA) uptake measurements were performed with A. nidulans
germinating conidiospores concentrated at 107 conidiospores per 100 ml at 37 C,
pH 6.8, at a deﬁned developmental stage, in which UapA and other transporters
show maximal expression, as previously described54. Competition experiments of
[3H]-xanthine uptake were carried out with increasing concentrations of unlabelled
hypoxanthine (1–1,000 mM). All transport assays were carried out in at least three
independent experiments, with three replicates for each concentration or time
point and s.d. was o20 % in all cases.
Molecular dynamics. The protein was prepared for molecular simulation
studies using the Protein Preparation Workﬂow (Schro¨dinger Suite 2015 Protein
Preparation Wizard) implemented in the Scho¨dinger suite and accessible from
within the Maestro programme (Maestro, version 10, Schro¨dinger, LLC, New York,
NY, 2015). Brieﬂy, the hydrogen atoms were added and the orientation of hydroxyl
groups, Asn, Gln, and the protonation state of His were optimized to maximize
hydrogen bonding. Finally, the ligand–protein complex was reﬁned with a
restrained minimization performed by the Impref utility, based on the Impact
molecular mechanics engine (Impact version 6.6, Schro¨dinger, LLC, New York,
NY, 2015) and the OPLS2001 force ﬁeld, setting a maximum root mean squared
difference of 0.30. Ligand preparation for docking was performed with the LigPrep
(LigPrep, version 2.5, Schro¨dinger, LLC, New York, NY, 2011) application that
consists of a series of steps that perform conversions, apply corrections to the
structure, generate ionization states and tautomers, and optimize the geometries.
The homodimeric WT UapA crystal structure with xanthine present in the
substrate-binding site of both monomers was utilized as the initial input structure.
For the MD simulations Desmond v.3 software was applied (Desmond Molecular
Dynamics System, version 3.8, D. E. Shaw Research, New York, NY, USA, 2008)55.
The system was prepared by embedding the protein in a POPC lipid bilayer,
solvating the membrane by TIP3P explicit water, neutralizing with counter ions
and adding 150mM salt. The stepwise equilibration protocol for membrane
proteins as developed by Desmond has been followed on eight steps. No driving
forces were applied to the ligand. The atomic Ca root mean squared difference of
the two monomeric units following equilibration was 1.05Å. Constant pressure
and constant temperature (NPT) runs were performed for 30 ns simulations in
three independent experiments with Langevin thermostat and barostat and semi
isotropic pressure restraints for the substrate studied (xanthine). Root mean
squared ﬂuctuation (RMSF) calculations were based on frame 0 as a reference
while Ca atoms of all residues were selected for RMSF calculation and ﬁtting.
Whole-residue RMSF ranged from 1Å for rigid secondary structural elements to
6 Å for mobile loops in both monomers similar to what has been observed for
membrane proteins. Figures were created with Maestro v10.1 (Schro¨dinger, LLC).
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms11336 ARTICLE
NATURE COMMUNICATIONS | 7:11336 | DOI: 10.1038/ncomms11336 |www.nature.com/naturecommunications 7
All trajectory analysis was performed using the Simulation Event Analysis as
implemented in Maestro version 10.
Preparation and analysis of the 8-bromoxanthine. Bromine (3.29mmol) was
added to a solution of xanthine (1.31mmol) in water (1.3ml). The resultant
mixture was reﬂuxed for 2 h. After the solution had cooled to room temperature,
the product was isolated by ﬁltration. The product was washed sequentially with
water (2 10ml) and diethyl ether (2 10ml) and subsequently dried in vacuo to
give 8-bromo-1H-purine-2,6(3H,7H)-dione, abbreviated to 8-bromoxanthine in
the manuscript. The ﬁnal yield of material was 0.64mmol, a yield of 49%. 1H NMR
analysis was used to conﬁrm the absence of trace xanthine impurity in the product.
The pure 8-bromoxanthine was used for co-crystallization, fungal growth assays
and transporter uptake assays (as detailed above). Where 8-bromoxanthine
was used, this replaced xanthine during all the steps of puriﬁcation of
UapAG411VD1–11 and crystals were obtained in the same conditions as
with xanthine, both as described above. Data were collected at a wavelength of
0.9 Å and subjected to processing as described above with the non-derivatized
xanthine.
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